Testing the Feasibility of a Virtual Application to Support Breast and Colorectal Cancer Survivors

Официальное название

Testing the Feasibility of a Virtual Application to Support Breast and Colorectal Cancer Survivors After Completing Primary Treatment

Обзор

The goal of this study is to determine the feasibility of implementing a mobile health application for breast and colorectal cancer survivors following primary treatment. Developed in collaboration with Seamless MD, the intervention acts as an information hub, providing users with timely and evidence-based information related to follow-up care as well as health system/community-based resources and programs to meet their needs during this period of care. The goal of the intervention is to encourage open communication regarding survivorship expectations and provide survivors with appropriate information and support to meet their needs. This study will: 1. Test the feasibility of implementing the virtual intervention at two cancer centres in Atlantic Canada (Nova Scotia and New Brunswick) 2. Gather feedback regarding the intervention from cancer survivors and healthcare providers. Participants will have access to the intervention for a period of six months. Questionnaires will be distributed to participants through the intervention at baseline, 90 days, and 180 days to assess user experience. Semi-structured interviews will be conducted with select survivor participants and healthcare providers (oncology and primary care) to determine the feasibility and acceptability of this intervention.

Вмешательства

• Поведенческое virtual self-management intervention
  The intervention is a supportive information and self-management tool housed on the SeamlessMD mobile app, created in collaboration with the SeamlessMD development program and informed by foundational research. The application will be used as an information hub and self-management/navigation tool alongside usual care, to address the physical, psychosocial, and practical needs of breast and colorectal cancer survivors. Note that the intervention will not seek to change or impact a survivor's foll

Первичные конечные точки

• Recruitment [Срок оценки: During enrollment]
• Retention [Срок оценки: Enrollment to day 180]
• Usage of the Intervention [Срок оценки: Baseline to day 180]
• Survivor and Provider Acceptability and Experience [Срок оценки: Interviews with survivor participants will be conducted after having access to the intervention for 180 days.]

Вторичные конечные точки (3)

• Fear of Recurrence [Срок оценки: Outcomes will be captured at baseline (study entry), on days 90 and 180, directly through the Seamless MD app software.]
• Patient Activation [Срок оценки: Outcomes will be captured at baseline (study entry), on days 90 and 180, directly through the Seamless MD app software.]
• Information Provision [Срок оценки: Outcomes will be captured at baseline (study entry), on days 90 and 180, directly through the Seamless MD app software.]

Критерии участия

Критерии включения

• Adults older than 18 years, capable of providing informed consent
• Diagnosed with stage I-III breast or colorectal cancer, and have completed primary treatment for their cancer (surgery and/or adjuvant systemic or radiation therapy) 6 months - 5 years ago

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Не применимо

Модель

Одна группа

Маскирование

Открытое

Основная цель

Поддерживающая терапия

Центры проведения

Канада · 2 центра

• Saint John Regional Hospital — Saint John
• Centre for Clinical Research QEII Health Sciences Centre — Halifax

Идентификаторы

NCT: NCT07312786 · 707168

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗